ROC analysis was conducted to evaluate the potential value of SLC35A3 as a diagnostic biomarker for differentiating CRC tissues from normal tissues in the TCGA-COADREAD, GSE87211, GSE21510, ICGC-COAD, and ICGC-READ datasets. Here, SLC35A3 is linked to colorectal carcinoma.